Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Long-Acting Reversible Contraceptive Methods

Continuation rates among young, nulliparous females

Long-acting reversible contraceptive (LARC) continuation rates were high and similar across age and parity and clinicians should not hesitate to recommend LARC methods to young nulliparous females, according to a study of 6,106 participants, including 863 aged 14 to 19 years. The analysis focuses on continuation of the intrauterine device and implant in nulliparous adolescents compared with parous, older women. Researchers found:

• LARC continuation rates at 12 months were high and similar between all age-parity groups ranging from 82% to 86%.

• Nulliparous participants using the copper intrauterine device and implant were more likely to discontinue their LARC method (adjusted HR=1.76) than parous participants.

• This was not observed among levonorgestrel intrauterine system users (adjusted HR=1.16).

• Age <20 years was not associated with discontinuation at 12 months (adjusted HR=0.95).

Citation: Abraham M, Zhao Q, Feipert JF. Young age, nulliparity, and continuation of long-acting reversible contraceptive methods. Obstet Gynecol. [Published online ahead of print September 3, 2015]. doi: 10.1097/AOG.0000000000001036.